TECH Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Merck KGaA Acquires Bio-Techne
Merck KGaA to acquire Bio-Techne for $73 per share in cash, representing a total enterprise value of approximately $11.3 billion
Merck Acquires Bio-Techne
Merck KGaA agrees to acquire Bio-Techne, strengthening its leadership position in life sciences markets